Correlation of Ramadan Fasting with HbA1C and Lipid Profile Level Changes in The Risk Stratification of Complications in Diabetes Mellitus Patients

Abstract

Introduction Ramadan fasting, observed by millions of Muslims globally, presents a unique and significant challenge for patients with diabetes mellitus. The prolonged abstinence from food and drink can profoundly impact metabolic control, creating concerns about glycemic and lipid profile changes and the associated risk of complications. This review synthesizes current literature to explore the multifaceted effects of Ramadan fasting on HbA1c levels and lipid profiles in diabetic patients.

Methods This abstract is based on a literature review that synthesizes findings from prospective observational studies, systematic reviews, and meta-analyses. The review examined the impact of Ramadan fasting on key metabolic markers, including HbA1c and lipid profiles, and assessed the incidence of glycemic complications in patients with type 1 and type 2 diabetes.

Results The evidence on the metabolic effects of Ramadan fasting is notably conflicting. Several studies demonstrate that with appropriate medical improved glycemic control and a reduction in HbA1c levels. Conversely, other research highlights a significant risk of metabolic deterioration, including a 7.5-fold increase in severe hypoglycemia and a fivefold increase in severe hyperglycemia. Many patients attempt to fast without medical consultation, and healthcare providers often report knowledge gaps in managing this population.

Discussion The variability in outcomes underscores that the safety of Ramadan fasting is highly dependent on individualized patient management rather than the act of fasting itself. The conflicting findings reveal that pre-fasting risk assessment, structured education, and tailored medication regimens are paramount to achieving beneficial outcomes and avoiding harm. The documented knowledge gaps among both patients and healthcare providers represent a critical barrier to the safe observance of Ramadan for individuals with diabetes, emphasizing the need for improved communication and guidelines.

Conclusion Ramadan fasting can have divergent effects on patients with diabetes, with the potential for both improved glycemic control and severe, life-threatening complications. The literature collectively stresses that safe fasting is contingent upon proactive, individualized management. A collaborative approach involving pre-Ramadan education, risk stratification, and continuous monitoring is essential to mitigate risks and optimize health outcomes.